All products are designed for the highest possible performance and are manufactured using a standardized process to ensure the most rigorous levels of quality.
Anti-RGN Antibody
Polyclonal Antibody against HUMAN RGN
0.2 mg/ml
Immunohistochemistry analysis in human adrenal gland and tonsil tissues using HPA029103 antibody. Corresponding RGN RNA-seq data are presented for the same tissues.
The Anti‑RGN antibody (HPA029103) is designed for sensitive detection of RGN (Regucalcin), an intracellular enzyme and metabolic protein with strong protein‑level evidence in the Human Protein Atlas. RGN shows group‑enriched RNA expression in the adrenal gland and liver, aligning with its placement in the “Non‑specific – Metabolism (mainly)” expression cluster.
Significance in Research: HPA protein profiling demonstrates cytoplasmic and nuclear expression in multiple metabolically active tissues, including hepatocytes, renal tubules, exocrine pancreas, and adrenal cortex, with clear cytosolic localization at the subcellular level. RGN also appears as a favourable prognostic marker in renal and liver cancers, expanding its relevance in oncology and metabolic disease research. This antibody is an excellent choice for studies in metabolism, liver and kidney biology, endocrine regulation, and RGN‑linked cancer pathways.
Alternative antibodies
Corresponding antigens
With Atlas Antibodies you get
From our facilities in Stockholm, Sweden we develop, manufacture and distribute highly advanced reagents to the Life Sciences community worldwide.
Our products are available to customers worldwide. From most locations, you can order our products from Atlas Antibodies. Please see more information about how to order here.
Learn how we validate our antibodies, how we secure their reproducibility, and why we apply enhanced validation. Our antibodies are validated in IHC, ICC-IF, and WB.